Bruce Taillon, formerly the director of healthcare business development at Roche's 454 Life Sciences division, is now the head of global technology business development at Enzo Life Science.
While the firm decided to cut some products from its menu and lay off some staff, its array-related offerings, such as its comparative genomic hybridization kits, will receive more investment going forward.
A streamlining of its Life Sciences and Clinical Labs operations is expected to result in a reduction of annualized operating expenditures of $4 million.
GeneNews recently presented a study that found ColonSentry "was able to detect right-sided CRC lesions across all stages with a sensitivity that is at least equal to the detection observed for left-sided lesions."
A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.
Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.
